Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Non-Current Deffered Revenue (2022 - 2024)

Vsee Health filings provide 3 years of Non-Current Deffered Revenue readings, the most recent being $69999.0 for Q4 2024.

  • On a quarterly basis, Non-Current Deffered Revenue fell 98.4% to $69999.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $69999.0, a 98.4% decrease, with the full-year FY2024 number at $69999.0, down 98.4% from a year prior.
  • Non-Current Deffered Revenue hit $69999.0 in Q4 2024 for Vsee Health, down from $4.4 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $4.4 million in Q4 2022 to a low of $69999.0 in Q4 2024.
  • Median Non-Current Deffered Revenue over the past 3 years was $4.4 million (2022), compared with a mean of $3.8 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: changed 0.0% in 2023 and later tumbled 98.4% in 2024.
  • Vsee Health's Non-Current Deffered Revenue stood at $4.4 million in 2022, then changed by 0.0% to $4.4 million in 2023, then tumbled by 98.4% to $69999.0 in 2024.
  • The last three reported values for Non-Current Deffered Revenue were $69999.0 (Q4 2024), $4.4 million (Q1 2024), and $4.4 million (Q4 2023) per Business Quant data.